skip to content

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.